Anticipation of age at onset in multiple sclerosis: Methodologic pitfalls

Acta Neurologica Scandinavica

Volumn 121, Issue 6, 2010, Pages 426-428

  Alonso Magdalena, L ^a   Romero Pinel, L ^b   Moral, E ^b   Carmona, O ^b   Gubieras, L ^b   Ramon J M ^b   Martinez Yelamos S ^b   Arbizu, T ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Age at onset; Anticipation; Demyelinating diseases; Epidemiology; Multiple sclerosis; Natural history

Indexed keywords

ADULT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NOTE; ONSET AGE; SEX RATIO; SPAIN; SURVIVAL; AGE; AGING; DISEASE COURSE; GENETIC SUSCEPTIBILITY; GENETICS; MORTALITY; STATISTICAL BIAS; TIME;

AGE FACTORS; AGE OF ONSET; AGING; ANTICIPATION, GENETIC; BIAS (EPIDEMIOLOGY); DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIPLE SCLEROSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 77952594650     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01273.x     Document Type: Note

References (13)

1. O'connor P, Canadian multiple sclerosis working group. Key issues in the diagnosis and treatment of multiple sclerosis: an overview. Neurology 2002 59 (6 Suppl. 3 S1-33.
2. Cocco E, Sardu C, Lai M, Spinicci G, Contu P, Marrosu MG. Anticipation of age at onset in multiple sclerosis. A Sardinian cohort study. Neurology 2004 62: 1794-1798.
3. Hodge SE, Wickramaratne P. Statistical pitfalls in detecting age-of-onset anticipation: the role of correlation in studying anticipation and detecting ascertainment bias. Psychiatr Genet 1995 5: 43-7.
4. Picco MF, Goodman S, Reed J, Bayless TM. Methodological pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med 2001 134: 1124-1129.
5. Confavreux C, Compston DA, Hommes OR, Mcdonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992 55: 671-676.
6. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13: 227-231.
7. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical trials of New Agents in Multiple Sclerosis. Neurology 1996 46: 907-911.
8. Thompson AJ, Montalbán X, Barkhof F et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000 47: 831-835.
9. Poser C. Onset symtoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995 58: 253-254.
10. Rabinowitz D, Yang Q. Testing for age-at-onset anticipation with affected parents-child pairs. Biometrics 1999 55: 834-838.
11. Ahlgren C, Odén A, Torén K, Andersen O. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 2009 119: 313-320.
12. Alonso A, Hernán MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008 117: 15-20.
13. Orton SM, Herrera BM, Yee IM et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006 5: 932 936.